American Hip Institute Research Foundation, Chicago, Illinois.
American Hip Institute Research Foundation, Chicago, Illinois; AMITA Health St. Alexius Medical Center, Hoffman Estates, Illinois.
Arthroscopy. 2022 Jun;38(6):1879-1887. doi: 10.1016/j.arthro.2021.11.040. Epub 2021 Dec 1.
Data were prospectively collected and retrospectively reviewed for professional, collegiate, and high school athletes between April 2008 and October 2015, who underwent primary hip arthroscopy. Athletes were considered eligible if they did not return to sport for reasons unrelated to their hip such as loss of interest, graduation, or a lifestyle transition (T athletes). Inclusion criteria were preoperative and minimum 5-year postoperative patient-reported outcomes (PROs) for the modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and the visual analog scale (VAS) for pain. Clinical outcomes were assessed using the minimal clinically important difference (MCID) and maximum outcome improvement satisfaction threshold (MOIST). T athletes were then propensity-matched to a control group of high-level athletes who returned to sport after hip arthroscopy (RTS athletes) for comparison.
Twenty-seven T hips (25 patients) were included in the analysis with a mean follow-up time of 38.9 ± 16.8 and 72.1 ± 16.8 months for minimum 2- and 5-year outcomes, respectively. They demonstrated significant improvement in all measured PROs. When compared to a propensity-matched control group of RTS athletes, T athletes demonstrated similar improvement in PROs (mHHS, NAHS, and HOS-SSS) and achieved MCID at similar rates for NAHS (T: 77.8% vs RTS: 68.8%; P = .570) and HOS-SSS (T: 70.3% vs RTS: 76.6%, P = .824) compared to RTS athletes; however T athletes demonstrated higher rates of achieving MCID for mHHS (T: 88.9% vs RTS: 72.9% P = .033).
Athletes who did not return to sport for reasons unrelated to their hip demonstrated favorable outcomes at minimum 2- and 5-year follow-up. They had similar PROs and rates of achieving MCID for HOS-SSS compared to a propensity-matched control group of high-level athletes who returned to sport. Return to sport status may not necessarily be correlated to the patient's perception of their own outcome.
III, retrospective cohort study.
1)报告因与髋关节无关的原因而未重返运动(RTS)的高水平运动员髋关节镜术后至少 2 年和 5 年的结果(T 运动员),2)并将这些发现与因髋关节无关的原因而重返运动(RTS 运动员)的高水平运动员的倾向匹配对照组进行基准比较。
2008 年 4 月至 2015 年 10 月,对职业、大学和高中运动员进行了前瞻性数据收集和回顾性研究,他们接受了初次髋关节镜手术。如果运动员因与髋关节无关的原因(如兴趣丧失、毕业或生活方式转变)而不重返运动,则被认为符合入选标准(T 运动员)。纳入标准为术前和至少 5 年的改良 Harris 髋关节评分(mHHS)、非关节炎髋关节评分(NAHS)、髋关节结局评分-运动特异性量表(HOS-SSS)和疼痛视觉模拟量表(VAS)的术后患者报告结局(PROs)。临床结果使用最小临床重要差异(MCID)和最大结局改善满意度阈值(MOIST)进行评估。然后,将 T 运动员与因髋关节镜术后重返运动(RTS 运动员)的高水平运动员的倾向匹配对照组进行匹配比较。
27 个 T 髋关节(25 名患者)纳入分析,2 年和 5 年的最小随访时间分别为 38.9±16.8 和 72.1±16.8 个月。他们的所有测量 PROs 均有显著改善。与因髋关节无关的原因而重返运动(RTS 运动员)的倾向匹配对照组相比,T 运动员在 PROs(mHHS、NAHS 和 HOS-SSS)方面表现出相似的改善,并以相似的比率达到 NAHS(T:77.8%vs RTS:68.8%;P=0.570)和 HOS-SSS(T:70.3%vs RTS:76.6%,P=0.824)的 MCID;然而,T 运动员在 mHHS 方面达到 MCID 的比例更高(T:88.9%vs RTS:72.9%,P=0.033)。
因与髋关节无关的原因而未重返运动的运动员在至少 2 年和 5 年的随访中取得了良好的结果。他们在 HOS-SSS 方面的 PROs 和达到 MCID 的比率与因髋关节无关的原因而重返运动的倾向匹配对照组的高水平运动员相似。重返运动的状态可能与患者对自身结果的感知并不一定相关。
III,回顾性队列研究。